| 
          When the mutagenicity of isomers and homologues of MDI (4,4f-MDI,
      2,4f-MDI, a mixture of monomeric MDI isomers, and PMDI) was determined
      in the Salmonella/microsome test using DMSO and ethyleneglycol dimethyl ether (EGDE) as
      solvents, positive results were obtained for DMSO solutions of all four
      diisocyanates in the presence of S9 mix containing 30% S9 fraction. Uniformly
      negative results were found when the diisocyanates were dissolved in EGDE
      (Andersen et al., 1980; Herbold, 1980a,b; Woolrich, 1982; Shimizu et al.,
      1985; Zeiger, 1987; Herbold et al., 1998). MDI is not stable in DMSO, there being many products generated
      within minutes (Herbold, 1990; Gahlmann, 1993). Thus, it seems that positive
      test results in any in vitro test system are caused by the degradation products of MDI in DMSO, rather
      than by MDI itself. One of the degradation products of MDI is MDA, which
      is known to be genotoxic and whose formation was detected when MDI was
      dissolved in DMSO (Herbold et al., 1998). No MDA could be detected in solutions of MDI in EGDE. It is therefore
      concluded that the positive results obtained with diisocyanates in DMSO
      solutions are due to the formation of MDA. The stability of MDI in a model
      and a real-test environment was studied (Seel et al., 1999). When MDI was dissolved in DMSO, more than 99% of the MDI was degraded
      before the start of incubation with test ingredients of the Salmonella mutagenicity assay, and MDA was detected at 2.1-2.8% of the MDI concentration
      within 45 s of incubation. Tests assessing the mutagenic potential of MDI
      in vitro and in vivo show 
no convincing evidence of mutagenic activity. 
         Female Wistar rats were treated topically (on the back) with
      14C-MDI (labelled in the ring) in acetone to investigate the possibility
      of systemic circulation and DNA-binding potency of MDI (Vock & Lutz,
      1997). About 10% of the radioactivity was retained at the site of application.
      DNA radioactivity in the liver was at the limit of detection. In a second
      experiment using topical administration, 32P-postlabelling analysis did not reveal isocyanate-DNA adducts in the skin
      (Vock & Lutz, 1997). 
         Tissues obtained from female Wistar rats exposed to a 0.9-Κm
      aerosol of MDI for 17 h per day, 5 days per week, for 1 year, at levels
      of 0, 0.3, 0.7, or 2.0 mg/m3, were analysed for DNA adducts using a 
32P-postlabelling method (Vock et al., 1996). In the lung, neither isocyanate adducts nor the arylamine adduct
      was detectable. The same negative result was seen in the liver, bladder,
      kidney, respiratory epithelium, and peripheral lymphocytes. In the olfactory
      epithelium, on the other hand, the arylamine-derived DNA adduct nucleotides
      were detected at very low levels (5-10 adducts per 1010 nucleotides). 
       
      References 
       
      EAndersen M, Bineru ML, Kiel P, Larsen H, Maxild J (1980) Mutagenic action
      of isocyanates used in the production of polyurethanes. Scandinavian journal of 
work, environment & health, 6: 221-226. 
      EGahlmann R (1993) A critical review for the International Isocyanate 
Institute. June 1993. Wuppeltal, Bayer AG, Institute for Toxicology. 
      EHerbold B (1980a) [MDI Salmonella/microsome test for investigation 
of point mutation activity.] Wuppeltal, Bayer AG (unpublished; Bayer Report 
No. 9130, 9.5.1980) (in German). 
      EHerbold B (1980b) [MDI Salmonella/microsome test for investigation 
of point mutation activity.] Wuppeltal, Bayer AG (unpublished; Bayer Report 
No. 9341, 1.8.1980) (in German). 
      EHerbold B, Haas P, Seel K, Walber U (1998) Studies on the effect of the
      solvents dimethylsulfoxide and ethyleneglycoldimethylether on the mutagenicity
      of four types of diisocyanates in the Salmonella/microsome test. 
Mutation research, 412: 167-175. 
      EHerbold B (1990a) Special study, Salmonella/microsome test with 
Desmodur 44v20 using TA100. Wuppeltal, Bayer AG (unpublished; Bayer Report 
No. 19561, 27.9.1990). 
      EHerbold B (1990b) Special study, Salmonella/microsome test with 
Desmodur 44M (4,4f-MDI) using TA100. Wuppeltal, Bayer AG (unpublished; Bayer Report No. 19570, 27.9.1990). 
      ESeel K, Walber U, Herbold B, Kopp R (1999) Chemical behaviour of seven
      aromatic diisocyanates (toluenediisocyanates and diphenylmethanediisocyanates)
      under in vitro conditions in relationship to their results in the 
Salmonella/microsome test. Mutation research, 438:109?123. 
      EShimizu H, Suzuki Y, Takemura N, Goto S, Matsushita H (1985) The results
      of microbial mutation test for forty-three industrial chemicals. Sangyo Igaku 
(Japanese journal of industrial health), 27:400?417. 
      EVock EH, Hoymann HG, Heinrich U, Lutz WK (1996) 32P-postlabeling 
of a DNA adduct derived from 4,4f-methylenedianiline in the olfactory epithelium 
of rats exposed by inhalation to 4,4f-methylenediphenyl diisocyanate. 
Carcinogenesis, 17(5): 1069-1073. 
      EWoolrich PF (1982) Toxicology, industrial hygiene and medical control
      of TDI, MDI and PMPPI. American Industrial Hygiene Association journal, 43: 89-97 
      EZeiger E (1987) Salmonella mutagenicity test: III. Result from testing 
of 225 chemicals. Environmental mutagenesis, 9(9) :1-110. 
       |